Effects of naloxone on amphetamine induced striatal dopamine release in vivo: A microdialysis study

Life Sciences

Volumn 60, Issue 19, 1997, Pages 1659-1668

  Feigenbaum, Jeffery J ^a   Howard, Sherrel G ^b  

^a Executive House   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amphetamine; dopamine release; in vivo microdialysis; naloxone; striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID; NALOXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; RAT; STEREOTYPY;

ANIMALS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DRUG SYNERGISM; MALE; MICRODIALYSIS; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030908223     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00108-2     Document Type: Article

References (77)

1. C.A. SCHAD, J.B. JUSTICE JR., and S.G. HOLTZMAN, Soc. Neurosci. Abstr. 19 184 (1992)
2. M.S. HOOKS, D.N. JONES, J.B. JUSTICE JR., and S.G. HOLTZMAN, Pharmacol. Biochem. Behav. 42 765-770 (1992)
3. SCHAD, C.A., JUSTICE JR., and S.G. HOLTZMAN, Eur. J. Pharmacol. 275 9-16 (1995)
4. S.G. HOLTZMAN, J Pharmacol. Exp. Ther 189 51-80 (1974)
5. M. SKORUPSKA and R. LANGWINSKI, Pol. J. Pharmacol. Pharm. 41 401-411 (1989)
6. J.S. ANDREWS and S.G. HOLTZMAN, Neuropharmacology 26 1115-1120 (1987)
7. M. UKAI and T. KAMEYAMA, Brain Res. 238 378-380 (1985)
8. P.J. BUSHNELL, Pharmacol. Biochem. Behav. 25 161-170 (1986).
9. K.B.J. FRANKLIN and A. ROBERTSON, Pharmacol. Biochem. Behav. 16 433-436 (1982)
10. B.I. DIAMOND and R.L. BORISON, Neurology 28 1085-1088 (1978)
11. S. HABER, T. HATSUKAMI, P.A. BERGER, J.D. BARCHAS and H. AKIL, Prog. Neuropsychopharmacol. 2 425-430 (1978)
12. J.J. BILLINGS, KUNG, M.P., CHUMPRADIT, S., MOZLEY, D., ALAVI, A. and KUNG, H.F., J.Neurochem. 58 227-236 (1992)
13. R.M. KESSLER, M.S. ANSARI, D.E. SCHMIDT, T. de PAULIS, J.A. CLANTON, R. INNIS, M. AL-TIKRITI, R.G. MANNING and D. GILLESPIE, Life Sci. 49 617-628 (1991)
14. D. MALEC, S. FIDECKA and J. LANGWINSKI, Pol. J. Pharmacool. Pharm. 29 177-193 (1977)
15. S.G. MOYANOVA and S.P. ROUSSEVA, Acta Physiol. Bulg. 15 47-52 (1989)
16. J.J. BALSARA, N.V. NANDAL, N.P. BURTE, J.H. JADHAV and A.G. CHANDORKAR, Psychopharmacology 82 237-240 (1984)
17. J.J. FEIGENBAUM, J. YANAI, B.H. MOON, and H.L. KLAWANS, Neuropharmacology 22 1369-1376 (1983)
18. I. IZQUIERDO and N. GRAUDENEZ, Psychopharmacology 67 265-268 (1980)
19. S. FULGENITTI and L. CANCELA, Psychopharmacology 79 45-48 (1983)
20. J.J. FEIGENBAUM, J. YANAI, B.H. MOON and H.L. KLAWANS, Res. Comm. Subst. Abuse 3 379-382 (1982)
21. D.N. JONES and S.G. HOLTZMAN, J. Pharmacol. Exp. Ther. 262 638-645 (1992)
22. J.B. MALICK, M.L. BILLINGSLEY, R.K. KUBENA and J. M. GOLDSTEIN, Comm. Psychopharmcol. 1 475-488 (1977)
23. A. HORITA and M. CARINO, Life Sci. 23 1681-1686 (1978)
24. G. PAXINOS and C. WATSON, The rat brain in stereotaxic coordinates. Academic Press, New York (1986).
25. V. PETKOV and V. MARKOVSKA, Acta Physiol. Pharmacol. Bulg. 10 3-12 (1984).
26. L. EROGLÛ, E. GENÇ, and T. ALTUG, Pol. J. Pharmacol. Pharm. 36 1-6 (1984)
27. F. DAUDET, V. LEVIEL, C. KERNY, B. GUIBERT and C. BARBEERIS, Eur. J. Pharmacol. 95 199-205 (1983)
28. M.S. STARR, Life Sci. 37 2249-2255 (1985)
29. C. GAUCHY, M. DESBAN, M.O. KREBS, J. GLOWINSKI and M.L. KEMEL, Neuroscience 41 449-458 (1991)
30. M.L. KEMEL, M. DESBAN, J. GLOWINSKI and C. GAUCHY, Neuroscience 50 597-610 (1992)
31. C. GAUCHY, M.O. KREBS, M. DESBAN, J. GLOWINSKI and M.L. KEMEL, J. Neurochem. 61 Suppl. 252-259 (1993)
32. M.O. KREBS, C. GAUCHY, M. DESBAN, J. GLOWINSKI and M.L KEMEL, J. Neurosci. 14 2435-2443 (1994)
33. J.J. FEIGENBAUM and S. HOWARD, Life Sci 59 2009-2019 (1996)
34. L. TERENIUS, Ann. Rev. Pharmacol. Toxicol. 18 189-204 (1978)
35. R. FOG, Psychopharmacologia 16 305-312 (1970)
36. M. BABBINI and W.M. DAVIS, Brit. J. Pharmacol. 46 213-224 (1972)
37. J. SCHEEL-KRÜGER, K. GOLEMBIOWSKA and E. MOGILNIKA, Psychopharmacology 53 55-63 (1977)
38. K. KUSCHINSKY and O. HORNYKIEWICZ, Eur. J. Pharmacol. 26 41-50 (1974)
39. T. OKA and E. HOSOYA, Neuropharmacology 16, 115-119 (1977)
40. E.T. IWAMOTO, J. Pharmacol. Exp. Ther. 217 451-460 (1981)
41. E. EIDELBERG and A. SCHWARTZ, Nature, Lond. 225 1152-1153 (1970)
42. P.A. BRODERICK, Life Sci. 36 2269-2275 (1985)
43. N. YONEHARA and D.H. CLOUET, J. Pharmacol. Exp. Ther. 231 38-42 (1984)
44. K. KUSCHINSKY, Experientia 22, 1365-1366 (1973)
45. P.A. BRODERICK and F.T. PHELAN, The International Narcotics Research Conference (INRC) '89. 501-506, Alan R. Liss, New York, (1990)
46. P.A. BRODERICK and F.T. PHELAN, Adv. Biosci. 75 209-212 (1989)
47. T.P. PIEPPONEN, J. MIKOLA, M. RUOTSALAINEN and L. AHTEE, Soc. Neurosci. Abstr. 21 1848 (1995)
48. C. BIANCHI, A. SINISCHALCHI, E. VERATTI and L. BEANI, Pharmacol. Res. Comm. 17 377-384 (1985)
49. T.C. WESTFALL, H. GRANT, L. NAES and M. MELDRUM, Eur. J. Pharmacol. 92 35-42 (1983)
50. M.S. STARR, J. Pharm. Pharmacol. 30 359-363 (1978)
51. M. MARIEN, J. BRIEN, and K. JHAMANDAS, Can. J. Physiol. Pharmacol. 61 43-60 (1983)
52. B. CELSEN and K. KUSCHINSKY, Naunyn-Schmied. Arch. Pharmacol. 284 159-165 (1974)
53. K. KUSCHINSKY, B. CELSEN and A. HUPPERTZ, Int. J. Clin. Pharmacol. 12 129-133 (1975)
54. P.S. WIDDOWSON and R.B. HOLMAN, J. Neurochem. 59, 157-163 (1992)
55. J.J. FEIGENBAUM and A. RECHES, Neurology 36, Suppl. 1 340, 1986
56. P.A. BRODERICK, E.L. GARDNER and H.M. VAN PRAAG, Biol. Psychiat. 19 45-54 (1984)
57. H. SAITO, Pharmacol. Biochem. Behav. 35, 231-235 (1990)
58. P.A. BRODERICK, C.D. BLAHA and R.F. LANE, Brain Res. 269 378-381 (1983)
59. L. AHTEE, T.P. PIEPPONEN and J. MIKKOLA, J. Pharmacol. Exp. Ther. 255 803-808 (1990)
60. C. SAITO, R. CALVET, X. GUITART, C. SOLSONA, and J. MARSAL, Toxicol. Appl. Pharmacol. 106 20-27 (1990)
61. J.M. CROWDER, D.K. NORRIS and H.F. BRADFORD, Biochem. Pharmacol. 35 2501-2507 (1986)
62. D.M. MICHAELSON, G. MCDOWALL and Y. SARNE, J. Neurochem. 43 614-618 (1984)
63. T. KAKUNAGA, H. KANETO and K. HANO, J. Pharmacol. Exp. Ther. 153 134-141 (1966)
64. T. KAKUNAGA, H. KANETO and K. HANO, Folio Pharmacol. Jap. 62 31-50 (1966)
65. M. KAVALIERS, Brain Res. 408 403-407 (1987)
66. C.H. LEE and B.A. BERKOWITZ, J. Pharmacol. Exp. Ther. 198 347-356 (1976)
67. C. ELA, Y. HASIN, and Y. EILAM, J. Mol. Cell. Cardiol. 25 599-613 (1993)
68. D.H. ROSS, M.A. MEDINA and H.L. CARDENAS, Science 186 63-64 (1974)
69. K. BLUM, S. FUTTERMAN, J. WALLACE and H.A. SCHWERTER, Nature 265 49-51 (1977)
70. P. ADAMSON, J.Z. XIANG, T. MANTZOURIDES, M.J. BRAMMER and I.C. CAMPBELL, Eur. J. Pharmacol. 174 63-70 (1989)
71. S.P. WELCH and W.L. DEWEY, J. Pharmacol. Exp. Ther. 239 320-326 (1990)
72. P. NAGY-KERESZTES and J.P. ROSENFLED, Brain Res. 208 234-239 (1981)
73. J. RABKIN, Clin. Exp. Pharmacol. Physiol. 18 431-438 (1991)
74. M. MANELLI, M. MAGGI, M. DE FEO, S. CUOMO, G. FORTI, F. MORONI and G. GUISTI, New Engl. J. Med. 308 654-655 (1983)
75. W.F. SIMONDS, A.M. BOOTH, K.B. THOR, N.L. OSTROWSKI, J.R. NAGEL and W.C. DE GROAT, Brain Res. 271 365-370 (1983)
76. P.F. VOON VOIGHTLANDER, M.C. OCHOA and R. A. LEWIS, Adv. Exp. Med. Biol._221 345-355 (1987)
77. J. SAWYNOK, C. PINSKY and F.S. LABELLA, Life Sci. 25 1621-1632 (1979)